Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer's disease

https://doi.org/10.1016/j.neuint.2015.10.011Get rights and content

Highlights

  • Neuroinflammation is a novel target for Alzheimer's disease (AD).

  • Need for long-term prevention or early treatment in humans.

  • Certain functional foods/neutraceuticals have anti-inflammatory activity.

  • These neutraceuticals should be tested in clinical trials in AD.

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder, characterized by deposition of amyloid plaques and neurofibrillary tangles, as well as microglial and astroglial activation, and, finally, leading to neuronal dysfunction and death. Current treatments for AD primarily focus on enhancement of cholinergic transmission. However, these treatments are only symptomatic, and no disease-modifying drug is available for the treatment of AD patients. This review will provide an overview of the antioxidant, anti-inflammatory, anti-amyloidogenic, neuroprotective, and cognition-enhancing effects of a variety of nutraceuticals including curcumin, apigenin, docosahexaenoic acid, epigallocatechin gallate, α-lipoic acid and resveratrol and their potential for AD prevention and treatment. We suggest that therapeutic use of these compounds might lead to a safe strategy to delay the onset of AD or slow down its progression. The continuing investigation of the potential of these substances is necessary as they are promising compounds to yield a possible remedy for this pervasive disease.

Section snippets

Alzheimer's disease – a global burden

Alzheimer's disease (AD) is a complex and heterogeneous progressive disorder of the central nervous system (CNS) (Fang et al., 2013, Singh and Guthikonda, 1997). The incidence of AD is about 35 million people worldwide that accounts for 10–15% of people aged 65 or older, and 35% of those 85 years and older. With increased life expectancies and an aging population, it is estimated that this figure will triple in the next 40 years, ensuing in increased healthcare costs worldwide.

Low grade, chronic neuroinflammation in Alzheimer's disease

Pro-inflammatory activation of astroglia and microglia has been observed in many neurodegenerative diseases such as Parkinson's and Alzheimer's disease, and even autism-spectrum and obsessive-compulsive disorders. Neurofibrillary tangles (composed of hyper-phosphorylated tau) and senile plaques (composed of beta-amyloid, Aβ) are major pathological hallmarks of AD, which is also characterized by a cholinergic deficit, thus current treatments primarily focus on enhancement of cholinergic

Neuroinflammation as a therapeutic target in Alzheimer's disease

In recent years, studies have focused on different nutritional approaches to benefit AD patients (Fig. 2). More specifically, foods rich in n-3 fatty acids, vitamins, and diverse groups of polyphenolic plant secondary metabolites have been shown to be effective against several AD pathologies (Stevenson and Hurst, 2007, Willis et al., 2010). For example, in a cross-sectional study, the association between adherence to a Mediterranean diet (MeDi) and risk for Alzheimer's disease (AD) and mild

Source

Curcumin, a diarylheptanoid polyphenol isolated from the rhizomes of Curcuma longa L. (Zingiberaceae, common name: turmeric) is a food spice used extensively in the Indian cuisine and Ayurvedic medicine (Ringman et al., 2005).

Pharmacokinetics

Curcumin penetrates into the CNS (Yang et al., 2005) and exerts a broad range of anti-inflammatory effects. In a study conducted in mice by Pan et al., oral administration of a large dose of curcumin (1000 mg/kg) produced only plasma levels as low as 0.13 μg/mL after

Source

Apigenin (4′,5,7-trihydroxyflavone) is a flavonoid particularly abundant in the ligulate flowers of the chamomile plant (68% apigenin of total flavonoids) (McKay and Blumberg, 2006) and also found in other sources such as celery (4.61 mg/100 g), parsley (302 mg/100 g), peppermint (8.71 mg/100 g) (Shukla and Gupta, 2010).

Pharmacokinetics

Apigenin crosses the BBB, and concentrations in the cerebellar granule brain cells of the rat have reached 1.2 μM after daily i.p. administration of 20 mg/kg of apigenin

Source

Unfermented teas (Green and White) are derived from the steamed and dried leaves of the Camellia sinensis plant. Polyphenols from green tea have been shown to be powerful hydrogen-donating antioxidants, free radical scavengers of ROS and RNS in vitro (Mandel et al., 2004). Among the green tea polyphenols, a subclass termed catechins has received the greatest attention, of which green tea is one of the best-known dietary sources. Of the four major tea catechins in fresh tea leaves, (-)

Source

Docosahexaenoic acid is an essential omega-3 (n-3) polyunsaturated fatty acid (PUFA) that is found abundantly in marine fish. DHA is known to be the most important n-3 PUFA in the brain, accounting for roughly 15% of total fatty acids in grey matter, where it is enriched at synapses (Salem et al., 2001). Epidemiological data indicate that a low dietary intake of n-3 PUFA is a risk factor for AD (Lim et al., 2005), while people who ingest higher levels of DHA are less likely to develop cognition

Source

α-lipoic acid (ALA) is chemically synthesized, but can be considered a natural compound as it is a naturally occurring precursor of an essential cofactor for mitochondrial enzymes, including pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase (Maczurek et al., 2008, Münch et al., 2010).

Pharmacokinetics

ALA is a low molecular weight compound which easily penetrates the BBB (Biewenga et al., 1997). After crossing the BBB, ALA is absorbed into cells and tissues, which is then reduced to dihydrolipoate

Source

Resveratrol (3, 5, 4’ –trihydroxystilbene) is a polyphenolic phytoalexin, produced in response to damage in grapevines, pines and legumes, such as peanuts. It is also found in the “Itadori plant” (Polygonum cuspidatum) and tea (Burns et al., 2002, Langcake and Pryce, 1977, Soleas et al., 1997).

Pharmacokinetics

Resveratrol is poorly absorbed, and enhanced absorption is only seen with methylated analogs and piperine supplements (Kapetanovic et al., 2011). When resveratrol administered at a dose of 25 mg, the

Conclusion

This review provides a comprehensive overview of the antioxidant, anti-inflammatory, anti-amyloidogenic, neuroprotective and cognition-enhancing effects of curcumin, apigenin, EGCG, n-3 fatty acids, α-lipoic acid and resveratrol. These compounds have been examined in numerous in vitro and in vivo studies and many of their cellular targets identified. However, despite encouraging animal data, the percentage of positive human trials in AD is surprisingly low (as with many other drugs like

Acknowledgements

We thank Ralph Martins, Julian Castillo, Lezanne Ooi, Alejandra Rangel, Klaus Hager, Marlene Kenklies and Klaus Wessel for support and inspiration. We thank the National Health and Medical Research Council of Australia for funding (# 480102, to GM and MJS).

References (146)

  • N.S. Elsisi et al.

    Ibuprofen and apigenin induce apoptosis and cell cycle arrest in activated microglia

    Neurosci. Lett.

    (2005)
  • L. Fang et al.

    Design, synthesis and anti-Alzheimer properties of dimethylaminomethyl-substituted curcumin derivatives

    Bioorg. Med. Chem. Lett.

    (2014)
  • S. Gupta et al.

    Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells

    Biochem. Biophysical Res. Commun.

    (2001)
  • S.K. Ha et al.

    Apigenin inhibits the production of NO and PGE2 in microglia and inhibits neuronal cell death in a middle cerebral artery occlusion-induced focal ischemia mice model

    Neurochem. Int.

    (2008)
  • K. Hager et al.

    Alpha-lipoic acid as a new treatment option for Alzheimer type dementia

    Archives Gerontol. Geriatrics

    (2001)
  • M. Hashimoto et al.

    Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats

    J. Nutr.

    (2005)
  • L. Holmquist et al.

    Lipoic acid as a novel treatment for Alzheimer's disease and related dementias

    Pharmacol. Ther.

    (2007)
  • R.A. Isbrucker et al.

    Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies

    Food Chem. Toxicol.

    (2006)
  • S.S. Karuppagounder et al.

    Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease

    Neurochem. Int.

    (2009)
  • D.O. Kennedy et al.

    Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation

    Am. J. Clin. Nutr.

    (2010)
  • W.C. Kreisl et al.

    Comparison of [(11)C]-(R)-PK 11195 and [(11)C]PBR28, two radioligands for translocator protein (18 kDa) in human and monkey: Implications for positron emission tomographic imaging of this inflammation biomarker

    NeuroImage

    (2010)
  • A. Kunwar et al.

    Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and tumor cells

    Biochimica Biophysica Acta

    (2008)
  • L.D. Lawson et al.

    Absorption of eicosapentaenoic acid and docosahexaenoic acid from fish oil triacylglycerols or fish oil ethyl esters co-ingested with a high-fat meal

    Biochem. Biophysical Res. Commun.

    (1988)
  • C.L. Lin et al.

    Epigallocatechin gallate (EGCG) suppresses beta-amyloid-induced neurotoxicity through inhibiting c-Abl/FE65 nuclear translocation and GSK3 beta activation

    Neurobiol. Aging

    (2009)
  • G. Losi et al.

    Apigenin modulates GABAergic and glutamatergic transmission in cultured cortical neurons

    Eur. J. Pharmacol.

    (2004)
  • A. Maczurek et al.

    Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer's disease

    Adv. Drug Deliv. Rev.

    (2008)
  • R.E. Mrak et al.

    Glia and their cytokines in progression of neurodegeneration

    Neurobiol. Aging

    (2005)
  • A. Mullen et al.

    Anti-inflammatory effects of EPA and DHA are dependent upon time and dose-response elements associated with LPS stimulation in THP-1-derived macrophages

    J. Nutr. Biochem.

    (2010)
  • K. Ono et al.

    Alpha-lipoic acid exhibits anti-amyloidogenicity for beta-amyloid fibrils in vitro

    Biochem. Biophysical Res. Commun.

    (2006)
  • L. Packer et al.

    Neuroprotection by the metabolic antioxidant alpha-lipoic acid

    Free Radic. Biol. Med.

    (1997)
  • H.R. Park et al.

    Resveratrol inhibits the proliferation of neural progenitor cells and hippocampal neurogenesis

    J. Biol. Chem.

    (2012)
  • S.J. Park et al.

    Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases

    Cell

    (2012)
  • S.P. Patil et al.

    Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice

    Neuropharmacology

    (2014)
  • J.F. Quinn et al.

    Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice

    Neurobiol. Aging

    (2007)
  • B. Ray et al.

    Neuroinflammation in Alzheimer's disease: different molecular targets and potential therapeutic agents including curcumin

    Curr. Opin. Pharmacol.

    (2009)
  • P. Barberger-Gateau et al.

    Fish, meat, and risk of dementia: cohort study

    BMJ

    (2002)
  • L. Baum et al.

    Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease

    J. Clin. Psychopharmacol.

    (2008)
  • A.C. Bharti et al.

    Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells

    J. Immunol.

    (2003)
  • S. Borgwardt et al.

    Neural effects of green tea extract on dorsolateral prefrontal cortex

    Eur. J. Clin. Nutr.

    (2012)
  • J. Bradbury

    Docosahexaenoic acid (DHA): an ancient nutrient for the modern human brain

    Nutrients

    (2011)
  • N. Braidy et al.

    Neuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons

    FEBS J.

    (2010)
  • J. Burns et al.

    Plant foods and herbal sources of resveratrol

    J. Agric. Food Chem.

    (2002)
  • Z. Cai et al.

    Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease

    Int. J. Neurosci.

    (2014)
  • H. Capiralla et al.

    Resveratrol mitigates lipopolysaccharide- and Abeta-mediated microglial inflammation by inhibiting the TLR4/NF-kappaB/STAT signaling cascade

    J. Neurochem.

    (2012)
  • D.A. Carlson et al.

    The plasma pharmacokinetics of R-(+)-lipoic acid administered as sodium R-(+)-lipoate to healthy human subjects

    Altern. Med. Rev.

    (2007)
  • M.A. Castello et al.

    Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer's disease

    BMC Neurol.

    (2014)
  • D. Chandler et al.

    Effects of plant-derived polyphenols on TNF-alpha and nitric oxide production induced by advanced glycation endproducts

    Mol. Nutr. Food Res.

    (2010)
  • G.M. Cole et al.

    Neuroprotective effects of curcumin

    Adv. Exp. Med. Biol.

    (2007)
  • C.H. Cottart et al.

    Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans

    Mol. Nutr. Food Res.

    (2014)
  • K.H. Cox et al.

    Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population

    J. Psychopharmacol.

    (2015)
  • Cited by (0)

    View full text